A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

August 29, 2024

Study Completion Date

October 29, 2024

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Placebo

Placebo will be administered intravenously.

DRUG

Nipocalimab

Nipocalimab will be administered intravenously.

DRUG

Certolizumab

Certolizumab will be administered subcutaneously.

Trial Locations (32)

5700

Bekes Varmegyei Kozponti Korhaz Pandy Kalman Tagkorhaz, Gyula

6800

Porcika Klinika - Vasarhelyi Sarkanyfu Kft., Hódmezővásárhely

8000

CMed Rehabilitacios es Diagnosztikai Kozpont, Székesfehérvár

8200

Vital Medical Center Orvosi es Fogaszati Kozpont, Veszprém

16635

Altoona Center For Clinical Research, Duncansville

20095

Hamburger Rheuma Forschungszentrum II, Hamburg

30060

Atlanta Research Center for Rheumatology, Marietta

33324

Integral Rheumatology And Immunology Specialists, Plantation

33511

Bay Area Arthritis and Osteoporosis, Brandon

33765

Clinical Research of West Florida, Clearwater

40878

Rheumazentrum Ratingen, Ratingen

42101

Graves Gilbert Clinic, Bowling Green

44649

Rheumazentrum Ruhrgebiet, Herne

75150

Southwest Rheumatology Research LLC, Mesquite

85032

Arizona Arthritis and Rheumatology Research PLLC, Phoenix

91786

Inland Rheumatology Clinical Trials Inc., Upland

92648

Newport Huntington Medical Group, Huntington Beach

C1023AAB

STAT Research S A, Buenos Aires

C1417

Centro Privado de Medicina Familiar, Buenos Aires

C1425EOE

Sanatorio Agote, Buenos Aires

C1426BOR

Hospital Central Militar Cirujano Mayor Dr Cosme Argerich, Buenos Aires

C1128AAF

Mautalen Salud e Investigacion, CABA

C1406AGA

ARCIS Salud SRL Aprillus asistencia e investigacion, CABA

T4000AXL

Centro de Investigaciones Medicas Tucuman, San Miguel de Tucumán

H-1027

Budai Irgalmasrendi Korhaz, Budapest

85-168

Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Bydgoszcz

05 830

NZOZ Lecznica MAK MED S C, Nadarzyn

00 874

MICS Centrum Medyczne Warszawa, Warsaw

02 665

Centrum Medyczne Reuma Park, Warsaw

EH4 2XU

Western General Hospital, Edinburgh

ME7 5NY

Medway NHS Foundation Trust, Gillingham

SE5 9RS

Kings College Hospital, London

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY